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ASAIO Journal 2019 Case Report
There are no reports of acute pump thrombosis in the latest, 
continuous flow left ventricular assist devices type HeartMate 
3, other than thrombus ingestion. We present a case of early 
thrombosis of the pump and outflow graft, necessitating acute 
pump and outflow graft replacement. A combination of low-
flow episodes and subtherapeutic levels of anticoagulation 
was the most likely cause. ASAIO Journal 2019; 65:e72–e74.
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Left ventricular assist device support may infrequently be 
complicated by acute thrombosis. So far, there have been no 
reports of reoperation for pump thrombosis in patients with a 
HeartMate 3 (HM3).1,2 We present a case of pump and outflow 
graft thrombosis in a patient with a HM3 device in the very 
early postoperative phase, needing urgent replacement of the 
pump and outflow graft.
Case Description
A 44-year-old man with end-stage heart failure because of 
dilated cardiomyopathy (left ventricle [LV] end diastolic di-
ameter 62 mm, left atrium 43 mm, no signs of LV thrombus) 
underwent implantation of a HM3 device as a bridge to 
transplantation. Preoperatively, the patient was on contin-
uous heparin intravenously, with therapeutic activated partial 
thromboplastin time (APTT), which was ceased 4 hours before 
surgery. He did not use platelet inhibitors, platelet count was 
202 × 109/l, prothrombin time international normalized ratio 
1.4. On postoperative day 1, transoesophageal echocardiog-
raphy (TEE) showed no signs of right ventricular failure, normal 
turbulence at in- and outflow cannulae, and no spontaneous 
echo contrast in the LV. However, a structure was seen in the 
left posterior aortic sinus, attached to the left coronary cusp 
(Figure 1A, and Supplementary Movie 1 and 2 [see Video 1, 
Supplemental Digital Content, http://links.lww.com/ASAIO/
A370 and Video 2, http://links.lww.com/ASAIO/A371]). The 
differential diagnosis was an evolving thrombus, because of 
stasis and absence of aortic valve opening, for which conser-
vative management with follow-up imaging was decided. The 
patient was extubated late on postoperative day 1.
Heparin was started on postoperative day 2, 10,000 units/
day by continuous infusion. On day 3, the patient was dis-
charged from the ICU with a heparin ratio of 1.2. However, 
later that day, there was a low-flow episode that resolved with 
a 500 ml fluid bolus. Echocardiographically, a tamponade was 
suspected. Heparin was ceased, and the patient went for urgent 
rethoracotomy. Intraoperative TEE showed a normal aortic valve 
and aortic sinus. Some pericardial effusion was evacuated, al-
though a tamponade could not be confirmed and in retrospect 
the suspected large pericardial effusion was a pleural effusion 
(600 ml). There were no signs of thrombus in the outflow graft. It 
was decided not to restart the heparin until the next day.
However, in the night, the patient deteriorated, cold and per-
spirating, with clinical features of cardiogenic shock and acute 
respiratory failure. The display of the HM3 console showed an 
increase in pump power (8W), high calculated flow (8.5 L/min) 
and normal pulsatility index (2.2). Lactate dehydrogenase level 
was increased to 411 u/l. The patient was reintubated, and ur-
gent TEE and CT scan were performed. TEE showed no flow in 
both outflow and inflow graft (Figure 1, B and C). The CT scan 
showed an occluded outflow graft, but no signs of kinking or 
external compression (Figure 1, D and E). Log file interrogation 
showed rotor imbalance and increase in noise in the previous 
18 hours (Figure 2). The patient underwent urgent HM3 pump 
and outflow graft replacement, using the original left apical 
button. Macroscopic inspection revealed extensive pump and 
outflow graft occlusion with thrombotic material (Figure 1, F 
and G). Postoperatively, HM3 flows were stable and no major 
new events occurred. Heparin was restarted on postoperative 
day 1, acetylsalicylic acid 80 mg/day was started on postop-
erative day 5, and the patient was discharged on oral vitamin 
K antagonist (target INR 2–3) and acetylsalicylic acid. Hema-
tologic work-up did not reveal any signs of antiphospholipid 
syndrome. The patient recovered prosperously and is currently 
New York Heart Association I after 12 months of follow-up.
Discussion
We present a case of early failure of a HM3 device, due to 
thrombosis in the pump and outflow graft. Device malfunc-
tioning has been described before in case reports, but in these 
cases this was caused by bleeding within the bend relief com-
pressing the outflow graft, kinking, or thrombosis in the pump 
because of suspected embolus ingestion.1,3–5 In our case, both 
the pump and the outflow graft were fully thrombosed, without 
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Figure 1. Images of the functioning and thrombosed LVAD. A: TEE on postoperative day 1, note the structure attached to the aortic valve 
(*), and the colour jet of the inflow of the HeartMate (HM) 3 flow in the ascending aorta (+). The aortic valve remained closed during the whole 
heart cycle. B: TEE on postoperative day 4, showing no colour jet of HM3 flow in the ascending aorta. Note that there is no sign of the struc-
ture seen in (A) attached to the aortic valve. The echocardiogram showed full opening and closing of the aortic valve. C: TEE on postoperative 
day 4, showing no flow in the direction of the HM3 inflow canula. D and E: CT images on postoperative day 4, showing the occluded ouflow 
graft (#), with contrast only in the distal part of the outflow graft. Arrow: Bend relief of the proximal part of the ouflow graft, coming from the 
HM3. E: Three-dimensional, volume rendered reconstruction of (D). With no contrast, the outflow graft itself is not visible as a seperate struc-
ture. F and G: Photograph of the explanted HM3 pump, the outflow graft has been removed, showing thrombus in the inflow side and pump 
of the heartmate (F) as well as in the outflow side of the HM3 (G). CT, computed tomography; TEE, transoesophageal echocardiography. 
Figure 2. Log files of HM3 from the start of therapy, until log file interrogation was done for suspected pump occlusion on postoperative day 
4. The red line shows motor noise (µm), the blue line shows motor displacement (µm). Note the rotor noise and displacement start to increase 
from the moment of low-flow alarms. HM, HeartMate.
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any signs of kinking or external compression, both on CT and 
intraoperatively. The HM3 was sent to the manufacturer for fur-
ther analysis. No mechanical defects could be found.
Most likely, thrombosis occurred because of a combina-
tion of not yet therapeutic anticoagulation and low-flow epi-
sodes. The HM3 manufacturer advises to start heparin after 
12–24 hours and start aspirin on postoperative day 2–3. 
However, following our local anticoagulation policy, con-
tinuous heparin is started in low dose on postoperative day 
1–2 (day 2 in this patient), and aspirin on postoperative day 
4–6. This regime was chosen to reduce the high rate of early 
rethoracotomy we experienced.6 Because of this conserva-
tive anticoagulation approach, and (retrospectively unjusti-
fied) rethoracotomy, APTT levels had not yet reached target 
values by the time pump thrombosis occurred. It seems un-
likely that the structure seen in the aortic sinus had migrated 
in the inflow cannula, because in that scenario the structure 
should have crossed an open aortic valve against normal flow 
direction.
In conclusion, this case report illustrates that thrombosis 
of a HM3 device can occur. In absence of a clear cause, 
anticoagulation still seems mandatory in the early phase, espe-
cially when there are low-flow episodes.
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